期刊文献+

血清miR-122和miR-130a在隐匿性乙型肝炎患者中的表达及诊断价值 被引量:2

Expression and Correlation of Serum MiR-122 and MiR-130a in Patients with Occult Hepatitis B
下载PDF
导出
摘要 目的:研究分析血清miR-122和miR-130a在隐匿性乙型肝炎患者中的表达及诊断价值。方法:选取2014年1月至2018年6月在我院诊断为隐匿性乙型肝炎47例患者作为隐匿性乙型肝炎组,选取同期在我院就诊的慢性乙型肝炎52例患者作为乙型肝炎组,同期来我院进行健康体检的66例正常人员作为对照组,比较3组人员血清miR-122及miR-130a的表达情况,分析血清miR-122及miR-130a对隐匿性乙型肝炎的诊断价值。结果:隐匿性乙型肝炎组患者miR-122表达明显低于对照组与乙型肝炎组(P<0.05);乙型肝炎组患者miR-122表达明显高于对照组(P<0.05)。隐匿性乙型肝炎组患者血清miR-130a表达明显高于乙型肝炎组与对照组(P<0.05);乙型肝炎组患者血清miR-130a表达明显高于对照组(P<0.05)。乙型肝炎组患者与对照组人群血清miR-130a/miR-122比值差异无统计学意义(P>0.05);隐匿性乙型肝炎组患者血清miR-130a/miR-122比值明显高于乙型肝炎组和对照组(P<0.05);隐匿性乙型肝炎组患者与乙型肝炎组比较血清miR-122、miR-130α以及miR-122联合miR-130α,其AUC值为0.779(95%CI:0.698~0.928)、0.679(95%CI:0602~0.889)、0.872(95%CI:0794~0.949);隐匿性乙型肝炎组患者与对照组比较上述3项指标其AUC值分别是0.794(95%CI:0.710~0.931)、0.693(95%CI:0.631~0.900)、0.847(95%CI:0.767~0.927)。结论:隐匿性乙型肝炎患者血清miR-122表达较低,miR-130a表达较高,联合检测miR-122和miR-130a对隐匿性乙型肝炎具有诊断价值。 Objective:To analyze the expression and correlation of serum miR-122 and miR-130a in patients with occult hepatitis B.Methods:47 patients diagnosed with occult hepatitis B in our hospital from January 2014 to June 2018 as occult hepatitis B group,52 patients with chronic hepatitis B as hepatitis B group and 66 patients with healthy physical examination as the control group.The expressions of serum miR-122 and miR-130 were compared between the three groups,and the diagnostic value of serum miR-122 and miR-130 for occult hepatitis B was analyzed.Results:The expression of miR-122 in the occult hepatitis B group was significantly lower than that in the control group and the hepatitis B group(P<0.05);the expression of miR-122 in the hepatitis B group was significantly higher than that in the control group(P<0.05).The expression of serum miR-130a in the occult hepatitis B group was significantly higher than that in the hepatitis B group and the control group(P<0.05);the expression of serum miR-130a in the hepatitis B group was significantly higher than that in the control group(P<0.05).There was no significant difference in serum miR-130a/miR-122 Ratio between the hepatitis B group and the control group(P>0.05).The ratio of serum microRNA-130a/microRNA-122 in recessive hepatitis B group was significantly higher than that in hepatitis B group and control group(P<0.05).The AUCs of serum miR-122 combined with serum miR-130a curve were 0.91 and 1.00,respectively,and the sensitivities were 0.91 and 0.85,respectively,and the specificities were 0.82 and 0.91,respectively.Conclusions:The expression of miR-122 is lower in patients with occult hepatitis B,and the expression of miR-130a is higher.The combination of miR-122 and miR-130a has some diagnostic value for occult hepatitis B.
作者 李艳琴 王萌 LI Yan-qin;WANG Meng(laboratory clinical,Hanzhong Central Hospital(Hanzhong Shaanxi,723000)China;不详)
出处 《中西医结合肝病杂志》 CAS 2020年第4期352-354,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基金 陕西省卫生厅项目(No.2015br0223)。
关键词 隐匿性乙型肝炎 血清miR-122 血清miR-130a 相关性 serum miR-122 serum miR-130a occult hepatitis B correlation
  • 相关文献

参考文献9

二级参考文献74

  • 1尹志华,叶志中,罗秀霞,何伟珍,徐珊.MicroRNAs在SLE患者外周血中的异常表达[J].细胞与分子免疫学杂志,2008,24(3):306-307. 被引量:5
  • 2陈名声,徐焰,郝晓柯,张永生,徐威,卢宝弼.血清性激素的水平对男性肺癌患者诊断的意义[J].中国肺癌杂志,2005,8(4):300-303. 被引量:11
  • 3中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].中华流行病学杂志,2006,27(1):79-88. 被引量:389
  • 4Zhao D, Bi G, Feng J, et al. Association of serum chemerin levels with acute ischemic stroke and carotid artery atherosclerosis in a chinese population [J]. Med Sci Monit, 2015, 21 : 3121-3128.
  • 5Fanou EM, Knight J, Aviv RI, et al. Effect of collaterals on clinical presentation, baseline imaging, complications, and outcome in acute stroke [J]. AJNR Am J Neuroradiol, 2015, 36 (12): 2285-2291. DOI: 10.3174/ajnr.A4453.
  • 6Singh SK, Pal BM, Girschick HJ, et al. MicroRNAs--micro in size but macro in function [J]. FEBS J, 2008, 275 (20): 4929-4944. DOI: 10.1111/j.1742-4658.2008.06624.x.
  • 7Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J]. Cell Res, 2008, 18 (10): 997-1006. DOI: 10.1038/ cr.2008.282.
  • 8Han SW, Kim SH, Lee JY, et al. A new subtype classification of ischemic stroke based on treatment and etiologic mechanism [J]. Eur Ncurol, 2007, 57 (2): 96-102. DOI: 10.1159/000098059.
  • 9Abe M, Kaizu K, Matsumoto K. A ease port of acute renal failure and fulminant hepatitis associated with edaravone administration in a cerebral infarction patient [J]. Ther Apher Dial, 2007, 11 (3): 235-240. DOI: 10.1111/j. 1744-9987.2007.00480.x.
  • 10Fischer L, Hummel M, Korfel A, et al. Differential micro- RNA expression in primary CNS and nodal diffuse large B-cell lymphomas [J]. Neuro Oncol, 2011, 13 (10): 1090-1098. DOI: 10.1093/neuonc/nor 107.

共引文献90

同被引文献31

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部